← Evidence map

TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial.

Fred Saad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

86 papers cite itlatest 60 shown

2024
…
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39279580